Unlike the homepage narrative (which focuses on goals), this page lists how we think about sequencing: visit length, vitals cadence, who holds the pen on orders, and which labs must be current before we unlock each modality. Exosome work emphasizes paracrine signaling windows; PDRN emphasizes tissue preparation and photobiomodulation pairing where offered; stem-cell–derived routes emphasize batch traceability. Dollar ranges below are indicative—final quotes attach after chart review on Reserve.
We specify particle-size acceptance bands, cold-chain handoffs, and the visit schedule for loading doses vs. maintenance. Language about “resetting” cells stays in patient education decks; here we document measurable endpoints we track with you and your PCP.
PDRN batches note salmon-source provenance, nuclease treatment steps, and contraindications (e.g., active malignancy pathways per policy). We pair microcirculation checks where our medical director mandates them—details in your individualized order set, not in a brochure paragraph.
Infusion logs capture lot release certificates, nurse double-sign, and infusion duration. We separate research-grade collections from commercial allogeneic lines; if your file qualifies only for one track, we tell you early to avoid false hope.
After chart completeness, you receive a written protocol ID. Sessions run only in credentialed rooms with crash-cart proximity rules our QA team audits quarterly. Follow-up intervals are protocol-specific (some weekly, some monthly)—your PDF schedule spells that out so you aren’t guessing from a generic web paragraph.
Ready to take the next step? Reserve a consultation and we’ll walk you through options and pricing.
Reserve a ConsultationWant background reading before you book? Our Articles hub explains stem-cell science, safety checklists, and how marketing often outpaces evidence—useful context alongside this clinical page.
For full program information and pricing, check back on this page or reserve a consultation to receive personalized details.